Citations

Clear

12 citation(s) found for "Gonzalez, Alejandro".

Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol
Dorsey-Treviño, Edgar Gerardo , Contreras-Garza, Belinda Maricela , González‐González, José Gerardo , Álvarez‐Villalobos, Neri Alejandro , Salcido‐Montenegro, Alejandro , González-Colmenero, Alejandro Díaz , González‐Nava, Victoria , Rodriguez‐Tamez, Giselle , Rodríguez‐Gutiérrez, René , Alvarez-Villalobos, Neri, Díaz González-Colmenero, Alejandro, Farrell, Ann M, González-Nava, Victoria, Rodríguez-Tamez, Giselle, Rodríguez-Gutiérrez, René , González-González, José Gerardo , Álvarez-Villalobos, Neri A , Farrell, Ann , Montori, Víctor M.

Mayo Clinic

BMJ Open | June 30, 2018 | Volume: 8 | Issue: 6 | Pages: e020692

10.1136/bmjopen-2017-020692 | PMID 29961013 Get It

Introduction Sodium glucose cotransporter 2 (SGLT-2) inhibitors are a relatively new drug-class of glucose-lowering medications. Several trials and systematic reviews have demonstrated their beneficial effect on some macrovascular outcomes. Their effect on microvascular outcomes has been reported as positive in several trials, however, their effect remains uncertain. Therefore, we report the protocol of a systematic review and meta-analysis aimed at determining the effect of SGLT-2 inhibitors regarding patient-important and surrogate microvascular outcomes in patients with type 2 diabetes. Methods and analysis A comprehensive search will be conducted to find eligible articles from each database’s earliest inception to November 2017. These databases will include Ovid, MEDLINE, EMBASE, Web of Science, and Scopus. We will search for randomized controlled trials (RCTs) that compare any of the SGLT-2 inhibitors with any other active treatment or placebo assessing microvascular outcomes in either their primary or secondary outcomes. Reviewers working independently and in duplicate will review all abstracts, and full-text manuscripts for eligibility, and will systematically extract the data and will assess the risk of bias in the included studies. Random-effects models will also be used. Ethics and dissemination The results of the systematic review will be disseminated via publication in a peer-reviewed journal regardless of outcome and will be presented at relevant conferences. The data we will use do not include individual patient data, so ethical approval is not required PROSPERO registration number CRD42017076460.
Acetabular Component Orientation in Total Hip Arthroplasty: The Impact of Obesity
McArthur, Benjamin A., Vulcano, Ettore , Cross, Michael B. , Nguyen, Joseph , Valle, Alejandro González Della , Salvati, Eduardo A.

Mayo Clinic

HIP International | January 20, 2015 | Volume: 24 | Issue: 3 | Pages: 263-269

10.5301/hipint.5000125 | PMID 24817400 Get It

Introduction Acetabular component position can be an important determinant of joint stability and bearing surface wear after THA. Nonetheless, the incidence of malpositioning is high. Patient obesity, low surgeon volume, and minimally invasive approaches are known risk factors for malposition. As the incidence of obesity continues to increase, it is important to recognise its effect on intraoperative component positioning in THA. Objectives Our goal was to assess the impact of obesity on component position for a high-volume surgeon using a standard postero-lateral approach. Methods A consecutive series of 120 obese (BMI >30, mean BMI 34.4) and 120 non-obese patients (mean BMI 25.4), who had undergone primary THA by a single surgeon, were included in our retrospective study. AP pelvis and cross-table radiographs obtained at the first postoperative visit were analysed using EBRA software to determine inclination and anteversion angles. Optimal position was defined as 30-45° of inclination and 5-25° of anteversion. Results Mean inclination and anteversion were 40.6 (+/-5.4°) and 16.6 (+/-5.5°) respectively, in the obese group and 39° (+/-5.0°) and 16.2° (+/-7.5°) in the non-obese group. In the obese group 89 (74%) patients were within the desired range for both measurements, 31 (26%) were out of range in at least one, compared to 91 (76%) and 29 (24%) in the non-obese group, respectively. The overall incidence of malpositioning was 25% for both groups. Among outliers, mean deviation from the optimal range was ≤3.8° in both groups. Conclusions The risk of component malpositioning in THA may be reduced when surgery is performed by an experienced, high volume surgeon utilising a standard posterolateral approach. In this setting the deleterious effect of obesity may be overcome.